Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background Older adults with chronic kidney disease (CKD) typically take more than five medications and have multiple prescribing physicians. Little however is known about how they prioritize their medical conditions or decide which medications to take. Methods Semistructured interviews (average length 40 minutes) with twenty community-dwelling adults with CKD stages 3-5D, receiving nephrology care at a tertiary referral center. Respondents were asked about medications, prescribing physicians, and medication-taking behaviors. We performed thematic analysis to explain patients’ decisions regarding medication prioritization, understanding, and adherence decisions. Results Participants (age range, 55–84 years; mean, 72) took 5–14 prescribed medications, had 2–9 physicians, and 5–11 comorbid conditions. All had assigned implicit priorities to their medications. While the majority expressed the intention to be adherent, many regularly skipped medications they considered less important. Most identified the prescribing physician and indication for each medication, but there was often substantial discordance between beliefs about medications and conventional medical opinion. Respondents prioritized medications based on the salience of the particular condition, perceived effects of the treatment, and on the barriers (physical, logistic, or financial) to taking the prescribed drug. Side effects of medications were common and anxiety-provoking, but discussions with the prescribing physician were often delayed or unfulfilling for the patient. Conclusions Polypharmacy in CKD patients leads to complex medication choices and adherence behaviors in this population. Most of the patients we interviewed had beliefs or priorities that were non-concordant with conventional medical opinion, but patients rarely discussed these beliefs and priorities, or the resultant poor medication adherence, with their physicians. Further study is needed to provide quantitative data on the magnitude of adherence barriers. It is likely that more effective communication about medication taking could improve patients’ health outcomes and reduce potential adverse drug events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Patient non-compliance: Deviance or reasoned decision-making?
Donovan, J. L., & Blake, D. R. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90206-6 · Cited by 785
Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004) · Medical Care · doi:10.1097/01.mlr.0000129496.05898.02 · Cited by 519
Research works printed but not linked: 20
- Dunbar-Jacob, 2001, Treatment adherence in chronic disease, J Clin Epidemiol, 54, S57, 10.1016/S0895-4356(01)00457-7 · DOI · Paper page
- Lacey, 2008, Barriers to adherence with glaucoma medications: a qualitative research study, Eye, 23, 924, 10.1038/eye.2008.103 · DOI · Paper page
- Laws, 2000, Taking antiretroviral therapy for HIV infection: learning from patients' stories, J Gen Intern Med, 15, 848, 10.1046/j.1525-1497.2000.90732.x · DOI
- 2002, K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, S1
- Watnick, 2003, The prevalence and treatment of depression among patients starting dialysis, Am J Kidney Dis, 41, 105, 10.1053/ajkd.2003.50029 · DOI · Paper page
- Unruh, 2005, Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients, Am J Kidney Dis, 46, 1107, 10.1053/j.ajkd.2005.09.002 · DOI
- Gehi, 2007, Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study, Arch Intern Med, 167, 1798, 10.1001/archinte.167.16.1798 · DOI · Paper page
- Burnier, 2006, Medication adherence and persistence as the cornerstone of effective antihypertensive therapy, Am J Hypertens, 19, 1190, 10.1016/j.amjhyper.2006.04.006 · DOI · Paper page
- De Bleser, 2009, Interventions to improve medication-adherence after transplantation: a systematic review, Transpl Int, 22, 780, 10.1111/j.1432-2277.2009.00881.x · DOI · Paper page
- Morrissey, 2007, Medication noncompliance and its implications in transplant recipients, Drugs, 67, 1463, 10.2165/00003495-200767100-00007 · DOI
- Elliott, 2007, Strategies for coping in a complex world: adherence behavior among older adults with chronic illness, J Gen Intern Med, 22, 805, 10.1007/s11606-007-0193-5 · DOI
- Rudd, 1979, In search of the gold standard for compliance measurement, Arch Intern Med, 139, 627, 10.1001/archinte.1979.03630430009004 · doi:10.1001/archinte.1979.03630430009004 · Paper page
- Bailie, 2005, Patterns of medication use in the RRI-CKD Study: focus on medications with cardiovascular effects, Nephrol Dial Transplant, 20, 1110, 10.1093/ndt/gfh771 · DOI
- Johnson, 2002, The medication adherence model: a guide for assessing medication taking, Res Theory Nurs Pract, 16, 179, 10.1891/rtnp.16.3.179.53008 · DOI
- Wilson, 2007, Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors, J Gen Intern Med, 22, 6, 10.1007/s11606-006-0093-0 · DOI · Paper page
- Williams, 2008, Adherence to multiple, prescribed medications in diabetic kidney disease: a qualitative study of consumers' and health professionals' perspectives, Int J Nurs Stud, 45, 1742, 10.1016/j.ijnurstu.2008.07.002 · DOI · Paper page
- Williams, 2009, The role of irrational thought in medicine adherence: people with diabetic kidney disease, J Adv Nurs, 65, 2108, 10.1111/j.1365-2648.2009.05077.x · DOI
- Devraj, 2009, Health literacy and kidney disease: toward a new line of research, Am J Kidney Dis, 53, 884, 10.1053/j.ajkd.2008.12.028 · DOI
- Paasche-Orlow, 2007, The causal pathways linking health literacy to health outcomes, Am J Health Behav, 31, S19, 10.5993/AJHB.31.s1.4 · DOI · Paper page
- Garrity, 1981, Medical compliance and the clinician-patient relationship: a review, Soc Sci Med E, 15, 215
Cited by
Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071100 · Cited by 470
Management of Hypertension in Chronic Kidney Disease
Pugh, D., Gallacher, P. J., & Dhaun, N. (2019) · Drugs · doi:10.1007/s40265-019-1064-1 · Cited by 401
Medication Adherence in Older Adults With Cognitive Impairment: A Systematic Evidence-Based Review
Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.004 · Cited by 206
Mechta Nielsen, T., Frøjk Juhl, M., Feldt-Rasmussen, B., & Thomsen, T. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfx140 · Cited by 111
Kobue, B., Moch, S., & Watermeyer, J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2246-8 · Cited by 22
Metadata
- Authors
- Rifkin, D. E., Laws, M. B., Rao, M., Balakrishnan, V. S., Sarnak, M. J., & Wilson, I. B.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 56
- Issue
- 3
- Pages
- 439-446
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2157466490
- Cited by
- 126
- References
- 5
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.